Imugene prepares pivotal azer-cel trial with FDA - ICYMI
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
3 months ago
proactiveinvestors.com.au
Leslie Chong, Imugene CEO - Money News
Leslie Chong, Imugene CEO - Money News
7 months ago
omny.fm
Imugene annonce des taux de réponse record dans un essai de phase 1 pour un candidat traitement du lymphome diffus à grandes cellules B
Imugene annonce des taux de réponse record dans un essai de …
7 months ago
zonebourse.com
S&P/ASX 200 Accumulated Chart - Investing.com AU
S&P/ASX 200 Accumulated Chart - Investing.com AU
Aug 3, 2015
investing.com
Imugene teams with ABL to bring VAXINIA into next clinical chapter
Imugene teams with ABL to bring VAXINIA into next clinical chapter
Oct 18, 2022
proactiveinvestors.com.au
Imugene advances Phase 1 MAST trial for cancer-killing VAXINIA virus
Imugene advances Phase 1 MAST trial for cancer-killing VAXINIA virus
Nov 1, 2023
proactiveinvestors.com
Imugene doses first patient for VAXINIA bile tract cancer trial in Melbourne
Imugene doses first patient for VAXINIA bile tract cancer trial in M…
Jul 9, 2024
proactiveinvestors.com
Imugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial …
Dec 5, 2023
proactiveinvestors.com.au
Imugene welcomes positive FDA feedback on improved manufactur…
Sep 10, 2023
proactiveinvestors.com
Imugene Limited: Imugene's oncolytic virotherapy VAXINIA an…
Apr 9, 2024
finanznachrichten.de
Imugene seeks to activate immune system of cancer patients to identi…
4 months ago
proactiveinvestors.co.uk
Imugene and City of Hope dose first patient in cohort 3 of phase 1 trial …
Aug 9, 2022
proactiveinvestors.com
1:08
Wednesday’s HotCopper Trends: Imugene scores FDA tick, Arizona …
11 months ago
MSNHotCopper.com
S&P/ASX 300 Chart - Investing.com AU
Aug 22, 2015
investing.com
Imugene well positioned to deliver 2024 milestones
Dec 29, 2023
proactiveinvestors.com.au
Imugene opens enrolment for Bile Tract Cancer expansion study
Apr 14, 2024
proactiveinvestors.com.au
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Nov 27, 2023
proactiveinvestors.com.au
Imugene off to strong start to 2023 with JP Morgan Healthcare Confer…
Jan 22, 2023
proactiveinvestors.com.au
Imugene sees positive early signals in Phase 1 VAXINIA study
Nov 6, 2023
proactiveinvestors.com.au
Imugene In Deal With Merck KGaA, Pfizer To Evaluate HER-Vaxx - Ave…
Nov 17, 2021
nasdaq.com
Imugene gets development roadmap for cancer vaccine from FDA meet…
Mar 20, 2019
proactiveinvestors.com.au
Imugene doses first patient in VAXINIA IV cohort 2 trials
Dec 5, 2022
proactiveinvestors.com.au
Imugene secures IND approval for first-in-class onCARlytics trial
May 19, 2023
proactiveinvestors.com
Imugene’s Phase 1 onCARlytics clinical trial doses first patient in i…
Feb 14, 2024
proactiveinvestors.com.au
Imugene and Kincell Bio form manufacturing and process devel…
Apr 16, 2024
proactiveinvestors.com.au
Imugene annonce un taux de réponse global de 79% pour son c…
6 months ago
zonebourse.com
Imugene wins US FDA approval to begin onCARlytics first-in-class cl…
May 19, 2023
proactiveinvestors.com
Imugene records positive final safety and efficacy data from Phas…
Jun 27, 2022
proactiveinvestors.com.au
Imugene partners with Kincell Bio; selling cell therapy manufacturin…
Apr 16, 2024
proactiveinvestors.com
Imugene trial: 75% response rate in diffuse large B-cell lymphoma
7 months ago
proactiveinvestors.com
See more videos
Static thumbnail place holder